MAGEB3 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-58828
Key Product Details
Species Reactivity
Human
Applications
Immunohistochemistry, Immunohistochemistry-Paraffin
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody was developed against a recombinant protein corresponding to the following amino acid sequence: TRGQTQDHQGAQITATNKKKVSFSSPLILGATIQKKSAGRSRSALKKPQRA
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for MAGEB3 Antibody
Immunohistochemistry-Paraffin: MAGEB3 Antibody [NBP2-58828]
Immunohistochemistry-Paraffin: MAGEB3 Antibody [NBP2-58828] - Immunohistochemical staining of human cerebral cortex shows moderate nuclear positivity in neuronal cells.Applications for MAGEB3 Antibody
Application
Recommended Usage
Immunohistochemistry
1:50 - 1:200
Immunohistochemistry-Paraffin
1:50 - 1:200
Application Notes
For IHC-Paraffin, HIER pH 6 retrieval is recommended.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS (pH 7.2) and 40% Glycerol
Preservative
0.02% Sodium Azide
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: MAGEB3
Alternate Names
CT3.5, MAGE-B3 antigen, melanoma antigen family B, 3, melanoma-associated antigen B3, member 5
Gene Symbol
MAGEB3
Additional MAGEB3 Products
Product Documents for MAGEB3 Antibody
Product Specific Notices for MAGEB3 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...